Date/Time: Friday, November 1, 2024 at 12 noon – 1 pm

Speaker: Stefan Riedel, M.D., Associate Professor of Pathology, Harvard Medical School; Associate Medical Director, Clinical Microbiology Laboratories, Beth Israel Deaconess Medical Center

Learning Objectives:

At the conclusion of this educational presentation, the participant will be able to:

  • Describe and understand the conventional methods used for antimicrobial susceptibility testing (AST).
  • Describe the current regulatory standards and requirements for AST interpretation and clinical use.
  • Describe emerging technologies for AST, including rapid AST test methods.
  • Describe and understand the regulatory requirements and standards for FDA clearance of emerging technologies.
Session date: 
11/01/2024 - 12:00pm to 1:00pm EDT
Location: 
Children's National Hospital
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
    The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 1.00 Completion

Please login or register to take this course.